Who We Are
Goodlife Access Team
Gad MURENZI
Director and Research Lead
"We cannot impact the health of Rwandans without innovation and evidence-based policy and practice. Africa deserves better!"
Dr. Gad Murenzi (MD, MPH, MMed) brings over 10 years of clinical research and fundraising experience including securing independent US NIH research funds. He previously served as the Director of the Einstein-Rwanda Research and Capacity Building Program where he was responsible for leading scientific research and capacity building activities focused on HIV/HPV and related comorbidities. His research interests and expertise include HIV, cancer (mainly HPV related cancers) and other NCDs as well as mentoring of and building and/or strengthening research capacity for early-stage investigators and research teams. He is also the Managing Director of Goodlife Ivuriro.
Francine Miller
Public Health Lead
"Changing behavior saves lives. We just need to give people the tools to make informed decisions."
Francine Miller previously co-founded WellCall, a healthcare company based in San Francisco, which established a new model for the delivery of coaching and comprehensive prevention and wellness services to over 4 million members. WellCall was acquired by a leading Health Advocacy company. She is a seasoned healthcare professional with experience managing a $82 million corporate health budget, negotiating contracts and managing legislative activity regarding health policy.
Matthew Rehrig
Strategic Advisor
"Together we can find new ways to work across sectors and transform public health."
Matt brings 15+ years of experience as a global health implementer, donor, and advisor, now at Partners in Health. He previously served as Director, Markets at the Children's Investment Fund Foundation (CIFF), where he oversaw a portfolio of grant and market shaping investments in access to sexual & reproductive health products. Prior to that, he led business operations for healthcare enterprises in East Africa, including as Director of Business Operations for Jacaranda Health, a maternity care provider in Kenya.
Founding Advisory Board
Jean-Baptiste Mazarati
Dr. Jean-Baptiste Mazarati, Board Chair
"Rwanda deserves a better patient experience."
Advisor Jean-Baptiste is a professor at the University of Global Health Equity, and notably was the former head of Rwanda Biomedical Services- specifically the National Reference Lab, Blood Transfusion Services and Medical Technology Divisions. Jean-Baptiste holds a PhD in Tumor Biology and was previously a Jesuit priest.
Dr. Melsa Omaya
Board Member
"I believe we can save lives and empower patients with a holistic approach."
Advisor Melsa is a Fellow of the Ford Foundation Global Fellowship, an award she received in recognition of her efforts in expanding quality health services for the most vulnerable and especially gender based violence victims and children living with disabilities. Melsa is currently pursuing a masters degree (residency) in clinical oncology at the University of Nairobi and Kenyatta National Hospital. Previously she was the director of clinical services at Shining Hope for Communities (SHOFCO) in Kenya. Melsa is also a certified public accountant.
Josh Ruxin
Board Director, Goodlife Rwanda
"Health is the foundation of progress—together, we can bridge gaps, save lives, and create a healthier future for every Rwandan."
Josh Ruxin, Board Director Goodlife Rwanda, co-founded and served as CEO of Goodlife Pharmacies in Kenya and Uganda. Josh founded The Access Project and Health Builders, two NGOs which worked on primary health care and pharmacy across Rwanda and with his wife, Alissa Ruxin, founded Heaven and The Retreat in Kigali.
David Zapol
Board Director, Goodlife Ivuriro
"Innovation and compassion are the heartbeats of transformation—join us in transforming public health."
David Zapol was co-founder and COO at Goodlife Kenya and Uganda with Josh Ruxin, and founding CEO of Third Pole Therapeutics with his father, Warren Zapol. David was a strategy consultant with FSG working with Gates, Pfizer and other global health donors.